Clustering data with hclust algorithm for (Study ST002406)
Reversed phase NEGATIVE ION MODE (Analysis AN003923)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gluconasturtiin | ME569576 | 0.77 | 1.23 | 0.93 | 0.82 | 2.97 | 1.25 | 0.53 | 0.75 | 0.46 |
| Brassicanate A | ME569574 | 1.23 | 1.01 | 1.05 | 1.04 | 0.90 | 0.91 | 1.07 | 0.48 | 1.17 |
| 1,1^-diindolylmethane | ME569571 | 1.01 | 0.92 | 0.90 | 1.17 | 0.71 | 0.64 | 1.20 | 1.20 | 1.14 |
| Indole-3-carboxaldehyde | ME569577 | 1.30 | 1.26 | 1.05 | 0.75 | 0.76 | 0.66 | 0.91 | 1.02 | 0.81 |
| Neoglucobrassicin | ME569578 | 1.04 | 1.52 | 1.06 | 0.65 | 0.73 | 0.54 | 1.09 | 0.99 | 0.81 |
| Syringin | ME569580 | 1.64 | 1.37 | 1.67 | 1.03 | 0.87 | 1.12 | 0.20 | 0.37 | 0.17 |
| Rutalexin | ME569579 | 1.57 | 2.12 | 2.22 | 0.08 | 0.17 | 0.68 | 0.12 | 0.06 | 0.01 |
| Brassicanal A | ME569573 | 1.86 | 1.66 | 1.56 | 0.42 | 0.44 | 0.34 | 0.62 | 0.30 | 0.50 |
| 4-methoxyglucobrassicin | ME569572 | 1.58 | 2.16 | 1.14 | 0.32 | 0.54 | 0.39 | 0.68 | 0.67 | 0.31 |
| Glucobrassicin | ME569575 | 1.05 | 2.40 | 1.25 | 0.38 | 0.83 | 0.32 | 0.57 | 0.60 | 0.55 |
Factors:
| F1 | Developmental stage (DPI):day 14 | Silicon treatment [g]:0.0 |
| F2 | Developmental stage (DPI):day 14 | Silicon treatment [g]:0.5 |
| F3 | Developmental stage (DPI):day 14 | Silicon treatment [g]:1.0 |
| F4 | Developmental stage (DPI):day 21 | Silicon treatment [g]:0.0 |
| F5 | Developmental stage (DPI):day 21 | Silicon treatment [g]:0.5 |
| F6 | Developmental stage (DPI):day 21 | Silicon treatment [g]:1.0 |
| F7 | Developmental stage (DPI):day 7 | Silicon treatment [g]:0.0 |
| F8 | Developmental stage (DPI):day 7 | Silicon treatment [g]:0.5 |
| F9 | Developmental stage (DPI):day 7 | Silicon treatment [g]:1.0 |
